Modjtahedi H - Search Results

1

Molecular therapy of head and neck cancer.

Modjtahedi H. Modjtahedi H. Cancer Metastasis Rev. 2005 Jan;24(1):129-46. doi: 10.1007/s10555-005-5052-4. Cancer Metastasis Rev. 2005. PMID: 15785877 Review.

2

Significance of the c-erbB family of receptor tyrosine kinases in metastatic cancer and their potential as targets for immunotherapy.

Eccles SA, Modjtahedi H, Box G, Court W, Sandle J, Dean CJ. Eccles SA, et al. Among authors: modjtahedi h. Invasion Metastasis. 1994-1995;14(1-6):337-48. Invasion Metastasis. 1994. PMID: 7657527 Review.

3

Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction.

Modjtahedi H, Eccles S, Box G, Styles J, Dean C. Modjtahedi H, et al. Br J Cancer. 1993 Feb;67(2):254-61. doi: 10.1038/bjc.1993.49. Br J Cancer. 1993. PMID: 7679281 Free PMC article.

4

The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468.

Modjtahedi H, Styles JM, Dean CJ. Modjtahedi H, et al. Br J Cancer. 1993 Feb;67(2):247-53. doi: 10.1038/bjc.1993.48. Br J Cancer. 1993. PMID: 8094290 Free PMC article.

5

Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.

Modjtahedi H, Eccles S, Sandle J, Box G, Titley J, Dean C. Modjtahedi H, et al. Cancer Res. 1994 Apr 1;54(7):1695-701. Cancer Res. 1994. PMID: 8137284

6

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer.

Modjtahedi H, Hickish T, Nicolson M, Moore J, Styles J, Eccles S, Jackson E, Salter J, Sloane J, Spencer L, Priest K, Smith I, Dean C, Gore M. Modjtahedi H, et al. Br J Cancer. 1996 Jan;73(2):228-35. doi: 10.1038/bjc.1996.40. Br J Cancer. 1996. PMID: 8546911 Free PMC article. Clinical Trial.

7

Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.

O-charoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM, Eccles SA. O-charoenrat P, et al. Among authors: modjtahedi h. Cancer Res. 2000 Feb 15;60(4):1121-8. Cancer Res. 2000. PMID: 10706134

8

Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion.

O-Charoenrat P, Rhys-Evans P, Modjtahedi H, Court W, Box G, Eccles S. O-Charoenrat P, et al. Among authors: modjtahedi h. Int J Cancer. 2000 May 1;86(3):307-17. doi: 10.1002/(sici)1097-0215(20000501)86:3<307::aid-ijc2>3.0.co;2-i. Int J Cancer. 2000. PMID: 10760816 Free article.

9

Vascular endothelial growth factor family members are differentially regulated by c-erbB signaling in head and neck squamous carcinoma cells.

O-charoenrat P, Rhys-Evans P, Modjtahedi H, Eccles SA. O-charoenrat P, et al. Among authors: modjtahedi h. Clin Exp Metastasis. 2000;18(2):155-61. doi: 10.1023/a:1006764100867. Clin Exp Metastasis. 2000. PMID: 11235991

10

Targeting of cells expressing wild-type EGFR and type-III mutant EGFR (EGFRvIII) by anti-EGFR MAb ICR62: a two-pronged attack for tumour therapy.

Modjtahedi H, Moscatello DK, Box G, Green M, Shotton C, Lamb DJ, Reynolds LJ, Wong AJ, Dean C, Thomas H, Eccles S. Modjtahedi H, et al. Int J Cancer. 2003 Jun 10;105(2):273-80. doi: 10.1002/ijc.11055. Int J Cancer. 2003. PMID: 12673691 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page